Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 31 to 35 of 35 results for ascites

  1. Subcutaneous implantation of a battery-powered catheter drainage system for managing refractory and recurrent ascites (IPG479)

    This guidance has been updated and replaced by NICE interventional procedures guidance 631.

    Interventional procedures guidance
    Published
    23 February 2014

  2. Rifaximin for preventing episodes of overt hepatic encephalopathy (TA337)

    Evidence-based recommendations on rifaximin (Targaxan) for preventing episodes of hepatic encephalopathy in adults.

    Technology appraisal guidance
    Published
    25 March 2015
    View recommendations

    Sections for TA337

  3. Selective internal radiation therapies for treating hepatocellular carcinoma (TA688)

    Evidence-based recommendations on selective internal radiation therapies SIR-Spheres (Sirtex), TheraSphere (BTG) and QuiremSphere (Quirem Medical) for treating hepatocellular carcinoma in adults.

    Technology appraisal guidance
    Published
    31 March 2021
    View recommendations

    Sections for TA688

  4. Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment (DG16)

    Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the

    Diagnostics guidance
    Published
    10 December 2014
    View recommendations

    Sections for DG16

  5. Research recommendations

    research on subcutaneous automated low-flow pump implantation for refractory ascites should report details of patient selection, the...